Kappa opioids inhibit physiologically identified medullary pain modulating neurons and reduce morphine antinociception

Journal of Neurophysiology

Volumn 93, Issue 3, 2005, Pages 1138-1144

  Meng, I D ^a,c   Johansen, J P ^a   Harasawa, I ^a   Fields, H L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF NEW ENGLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NORBINALTORPHIMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; MALE; MICROINJECTION; MONITORING; NERVE CONDUCTION; NERVE EXCITABILITY; NONHUMAN; PAIN; POSTSYNAPTIC INHIBITION; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; PROPRIOCEPTION; RAT; TAIL FLICK TEST; THALAMUS VENTRAL NUCLEUS; TISSUE DISTRIBUTION;

ACTION POTENTIALS; ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; BENZENEACETAMIDES; DRUG INTERACTIONS; MALE; MEDULLA OBLONGATA; MICROINJECTIONS; MORPHINE; NEURAL INHIBITION; NEURONS; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PHYSICAL STIMULATION; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA;

EID: 14144255753     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.00320.2004     Document Type: Article

References (40)

1. Ackley M, Hurley R, Virnich D, and Hammond D. A cellular mechanism for the antinociceptive effect of a kappa opioid receptor agonist. Pain 91: 377-388, 2001.
2. Aimone L and Gebhart G. Stimulation-produced spinal inhibition from the midbrain in the rat is mediated by an excitatory amino acid neurotransmitter in the medial medulla. J Neurosci 6: 1803-1813, 1986.
3. Bederson JB, Fields HL, and Barbaro NM. Hyperalgesia during naloxone-precipitated withdrawal from morphine is associated with increased ON cell activity in the rostral ventromedial medulla. Somatosens Mot Res 7: 185-203, 1990.
4. Beitz A. Relationship of glutamate and aspartate to the periaqueductal gray-raphe magnus projection: analysis using immunocytochemistry and microdialysis. J Histochem Cytochem 38: 1755-1765, 1990.
5. Bie B and Pan ZZ. Presynaptic mechanism for anti-analgesic and anti-hyperalgesic actions of kappa-opioid receptors. J Neurosci 23: 7262-7268, 2003.
6. Budai D. A computer-controlled system for post-stimulus time histogram and wind-up studies. J Neurosci Methods 51: 205-211, 1994.
7. Fields HL and Basbaum AI. Central Nervous System Mechanisms of Pain Modulation. Edinburgh, UK: Churchill Livingstone, 1999.
8. Fields HL, Bry J, Hentall I, and Zorman G. The activity of neurons in the rostral medulla of the rat during withdrawal from noxious heat. J Neurosci 3: 545-552, 1983a.
9. Fields HL, Vanegas H, Hentall ID, and Zorman G. Evidence that disinhibition of brain stem neurones contributes to morphine analgesia. Nature 306: 684-686, 1983b.
10. Foo H and Helmstetter FJ. Activation of kappa opioid receptors in the rostral ventromedial medulla blocks stress-induced antinociception. Neuroreport 11: 3349-3352, 2000.
11. Gao K, Chen DO, Genzen JR, and Mason P. Activation of serotonergic neurons in the raphe magnus is not necessary for morphine analgesia. J Neurosci 18: 1860-1868, 1998.
12. Gardell LR, Vanderah TW, Gardell SE, Wang R, Ossipov MH, Lai J, and Porreca F. Enhanced evoked excitatory transmitter release in experimental neuropathy requires descending facilitation. J Neurosci 23: 8370-8379, 2003.
13. Gustein HB, Mansour A, Watson SJ, Akil H, and Fields HL. Mu and kappa opioid receptors in periaqueductal gray and rostral ventromedial medulla. Neuroreport 9: 1777-1781, 1998,
14. Harasawa I, Fields HL, and Meng ID. Delta opioid receptor mediated actions in the rostral ventromedial medulla on tail flick latency and nociceptive modulatory neurons. Pain 85: 255-262, 2000.
15. Heinricher M and McGaraughty S. Analysis of excitatory amino acid transmission within the rostral ventromedial medulla: implications for circuitry. Pain 75: 247-255, 1998.
16. Heinricher MM, McGaraughty S, and Farr DA. The role of excitatory amino acid transmission within the rostral ventromedial medulla in the antinociceptive actions of systemically administered morphine. Pain 81: 57-65, 1999.
17. Heinricher MM, McGaraughty S, and Tortorici V. Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla. J Neurophysiol 85: 280-286, 2001a.
18. Heinricher MM, Morgan MM, and Fields HL. Direct and indirect actions of morphine on medullary neurons that modulate nociception. Neuroscience 48: 533-543, 1992.
19. Heinricher MM, Morgan MM, Tortorici V, and Fields HL. Disinhibition of OFF cells and antinociception produced by an opioid action within the rostral ventromedial medulla. Neuroscience 63: 279-288, 1994.
20. Heinricher MM and Roychowdhury SM. Reflex-related activation of putative pain facilitating neurons in rostral ventromedial medulla requires excitatory amino acid transmission. Neuroscience 78: 1159-1165, 1997.
21. Heinricher MM, Schouten JC, and Jobst EE. Activation of brainstem N-methyl-D-aspartate receptors is required for the analgesic actions of morphine given systemically. Pain 92: 129-138, 2001b.
22. Heinricher MM and Tortorici V. Interference with GABA transmission in the rostral ventromedial medulla: disinhibition of OFF cells as a central mechanism in nociceptive modulation. Neuroscience 63: 533-546, 1994.
23. Kaplan H and Fields HL. Hyperalgesia during acute opioid abstinence: evidence for a nociceptive facilitating function of the rostral ventromedial medulla. J Neurosci 11: 1433-1439, 1991.
24. Kim DH, Fields HL, and Barbaro NM. Morphine analgesia and acute physical dependence: rapid onset of two opposing, dose-related processes. Brain Res 516: 37-40, 1990.
25. Kovelowski CJ, Ossipov MH, Sun H, Lai J, Malan TP, and Porreca F. Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat. Pain 87: 265-273, 2000.
26. Mansour A, Fox CA, Akil H, and Watson SJ. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 18: 22-29, 1995.
27. Margolis EB, Hjelmstad GO, Bonci A, and Fields HL. Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons. J Neurosci 23: 9981-9986, 2003.
28. Marinelli S, Vaughan CW, Schnell SA, Wessendorf MW, and Christie MJ. Rostral ventromedial medulla neurons that project to the spinal cord express multiple opioid receptor phenotypes. J Neurosci 22: 10847-10855, 2002.
29. McGaraughty S and Heinricher MM. Microinjection of morphine into various amygdaloid nuclei differentially affects nociceptive responsiveness and RVM neuronal activity. Pain 96: 153-162, 2002.
30. Meng ID and Johansen JP. Antinociception and modulation of rostral ventromedial medulla neuronal activity by local infusion of a cannabinoid receptor agonist. Neuroscience 124: 685-693, 2004.
31. Pan Z, Williams J, and Osborne P. Opioid actions on single nucleus raphe magnus neurons from rat and guinea-pig in vitro. J Neurophysiol 427: 519-532, 1990.
32. Pan ZZ. mu-Opposing actions of the kappa-opioid receptor. Trends Pharmacol Sci 19: 94-98, 1998.
33. Pan ZZ, Tershner SA, and Fields HL. Cellular mechanism for anti-analgesic action of agonists of the kappa-opioid receptor. Nature 389: 382-385, 1997.
34. Paxinos G and Watson C. The Rat Brain in Stereotaxic Coordinates. New York: Academic Press, 1986.
35. Porreca F, Burgess SE, Gardell LR, Vanderah TW, Malan TP, Jr, Ossipov MH, Lappi DA, and Lai J. Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor. J Neurosci 21: 5281-5288, 2001.
36. Shippenberg TS, Bals-Kubik R, and Herz A. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J Pharmacol Exp Ther 265: 53-59, 1993.
37. Spanagel R, Herz A, and Shippenberg TS. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA 89: 2046-2050, 1992.
38. Spinella M, Cooper M, and Bodnar R. Excitatory amino acid antagonists in the rostral ventromedial medulla inhibit mesencephalic morphine analgesia in rats. Pain 64: 545-552, 1996.
39. Tershner SA, Mitchell JM, and Fields HL. Brainstem pain modulating circuitry is sexually dimorphic with respect to mu and kappa opioid receptor function. Pain 85: 153-159, 2000.
40. Yeung JC, Yaksh TL, and Rudy TA. Concurrent mapping of brain sites for sensitivity to the direct application of morphine and focal electrical stimulation in the production of antinociception in the rat. Pain 41: 23-40, 1977.